GGrantIndex
← Search

CORE--POPULATION STUDIES

$196,218P30FY2002CANIH

Fox Chase Cancer Center, Philadelphia PA

Investigators

Linked publications, trials & patents

Paper 39604567Paper 39602533Paper 39554190Paper 39546469Paper 39521739Paper 39514554Paper 39371220Paper 39345610Paper 39343653Paper 39223207Paper 39207123Paper 39189642Paper 39148468Paper 39137728Paper 39072643Paper 39060143Paper 39013784Paper 39003201Paper 38982062Paper 38976159Paper 38963567Paper 38914477Paper 38871720Paper 38865671Paper 38853421Paper 38835516Paper 38815457Paper 38811332Paper 38798370Paper 38766032Paper 38747616Paper 38678525Paper 38659828Paper 38639476Paper 38638131Paper 38600381Paper 38586274Paper 38586042Paper 38559274Paper 38547779Paper 38539515Paper 38464238Paper 38452871Paper 38432028Paper 38421650Paper 38377387Trial NCT04290585Trial NCT03177057Trial NCT02594826Trial NCT02132884Trial NCT02132858Trial NCT02132845Trial NCT02110953Trial NCT02092714Trial NCT02050009Trial NCT01982591Trial NCT01962948Trial NCT01934179Trial NCT01840150Trial NCT01462630Trial NCT01316757Trial NCT01212822Trial NCT00750009Trial NCT00509626Trial NCT00458588Trial NCT00436397Trial NCT00433524Trial NCT00084591Trial NCT00084539Trial NCT00084526Trial NCT00084513Trial NCT00066677Trial NCT00062322Trial NCT00062309Trial NCT00043108Trial NCT00039520Trial NCT00039507Trial NCT00022308Trial NCT00021398Trial NCT00021372Trial NCT00021346Trial NCT00021333Trial NCT00021320Trial NCT00005037Trial NCT00003264Trial NCT00003263Trial NCT00003109Patent 9533040Patent 9182383Patent 9101603Patent 8980258Patent 8685658Patent 8609437Patent 8580263Patent 8329873Patent 7332585Patent 7332580Patent 7129057Patent 6946275Patent 6617427

Abstract

Description: (Applicant's Description) The number of large and logistically intricate research projects at Fox Chase Cancer Center (FCCC) has been steadily increasing. Many FCCC studies, including those in epidemiology, cancer control and prevention, human genetics, behavioral medicine and some animal trials employ a variety of designs that are substantially more complex than typical cancer clinical trials conducted at FCCC. These studies require comprehensive data quality assurance, the collection of outcome data and often involve this facility in data analysis. In addition, the designs of these studies often include: collection of questionnaire, clinical and specimen data from large numbers of individuals (ranging from hundreds to tens of thousands); collection of longitudinal data; collection, storage and graphical display of pedigree data; online data entry and retrieval at multiple geographically distant centers; data collection using computer aided telephone interview systems; development of specimen inventory systems; case-control and nested case-control study designs; and distribution of scheduled, personalized mailings. The varied populations studied in these projects and the diversity and complexity of the designs require development of study-specific computer based tools to; provide critical project management and coordination, and for the collection, validation, storage, and retrieval of data. The purpose of the Population Studies Facility (PSF) is to facilitate research conducted by peer-review funded investigators at FCCC by providing them access to a productive team of highly skilled information systems professionals. PSF personnel have substantial expertise with state-of-the-art software engineering and design as applied to cancer research. The PSF functions include development of: (a) databases for the storage and manipulation of large quantities of questionnaire, clinical, and specimen data; (b) electronic data entry and retrieval systems; report generation software; (d) consistency and quality control systems; and (e) statistical software. The PSF has developed information systems that maintain data on over 140,000 study subjects. Over the last five years, this facility has provided services to 29 peer-review funded FCCC researchers in nine different programs, from all three divisions. When fully operational this facility will support 40-45 peer-review funded investigators from nine programs from all three divisions of the Center.

View original record on NIH RePORTER →